Hyaluronated imatinib liposomes with hybrid approach to target CD44 and P-gp overexpressing MDR cancer: an in-vitro, in-vivo and mechanistic investigation-Reference-Cited by-同舟云学术

Hyaluronated imatinib liposomes with hybrid approach to target CD44 and P-gp overexpressing MDR cancer: an in-vitro, in-vivo and mechanistic investigation

Published:2018-08-14 Issue:2 Volume:27 Page:183-192
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Negi Lalit Mohan¹,Talegaonkar Sushama²,Jaggi Manu³,Verma Anita K⁴

Affiliation:

1. Formulation Development, Innovation and Development Centre, Fresenius Kabi Oncology Ltd, Gurgaon, India;

2. Department of Pharmaceutics, Delhi Pharmaceutical Sciences and Research University, New Delhi, India;

3. Dabur Research Foundation, Ghaziabad, India;

4. Nanobiotech Lab Department of Zoology, Kirori Mal College, University of Delhi, New Delhi, India

Funder

Department of Biotechnology, Ministry of Science and Technology

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2018.1497039

Reference40 articles.

1. Multidrug resistance

2. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine

3. The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review

4. Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies

5. Turning the gun on cancer: Utilizing lysosomal P-glycoprotein as a new strategy to overcome multi-drug resistance

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ⁶⁸Ga‐labeled, imatinib encapsulated, theranostic liposomes: Formulation, characterization, and in vitro evaluation of anticancer activity;Drug Development Research;2023-11-27

2. CD44 mediated colon cancer targeting mutlifaceted lignin nanoparticles: Synthesis, in vitro characterization and in vivo efficacy studies;International Journal of Pharmaceutics;2023-08

3. Pharmacokinetics and pharmacodynamic evaluation of hyaluronic acid-modified imatinib-loaded PEGylated liposomes in CD44-positive Gist882 tumor-bearing mice;Journal of Liposome Research;2023-07-04

4. Semi-Synthetic Dihydrotestosterone Derivatives Modulate Inherent Multidrug Resistance and Sensitize Colon Cancer Cells to Chemotherapy;Pharmaceutics;2023-02-09

5. Hyalurosomes: a newer approach for drug delivery;Systems of Nanovesicular Drug Delivery;2022